We checked c.419‐43delT variant, in BMPR2 gene, in 57 patients with PAH, in 40 patients with GD and in 100 individuals from general population, found the deletion in 18% of patients with PAH, in 55% of patients with GD and in 10% of individuals from general population (Fig. 1). Here, BMPR2 is linked to pulmonary arterial hypertension.